SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-22-007406
Filing Date
2022-05-05
Accepted
2022-05-05 16:31:53
Documents
62
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 6-K tmb-20220331x6k.htm 6-K 21300
2 EX-99.1 tmb-20220331xex99d1.htm   iXBRL EX-99.1 723381
3 EX-99.2 tmb-20220331xex99d2.htm EX-99.2 482663
  Complete submission text file 0001558370-22-007406.txt   3854008

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20220331.xsd EX-101.SCH 48955
5 EX-101.CAL tmb-20220331_cal.xml EX-101.CAL 38919
6 EX-101.DEF tmb-20220331_def.xml EX-101.DEF 126716
7 EX-101.LAB tmb-20220331_lab.xml EX-101.LAB 299478
8 EX-101.PRE tmb-20220331_pre.xml EX-101.PRE 215699
56 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220331xex99d1_htm.xml XML 429410
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 22896907
SIC: 2834 Pharmaceutical Preparations